癌得清注射液的抗癌作用
Antitumoral Effect of Ederqini ingection
-
摘要: 本文用金黄色葡萄球菌(Staphylococcusaureus)、乙型溶血性链球菌(StreP－tococcushemolyticus)、卡介苗(BCG)、伤杆菌(Salmonellatyphi)等多种细菌抗原免疫SD大鼠,并从其脾脏、胸腺等淋巴组织通过透析的方法获得透析外液,再加上构才己等中药透析的小分子(MW≤10KD)物质,制备成混合制剂(癌得清)。然后以DBA/2小鼠荷L5178Y、P815肿瘤为模型,分别在肿瘤细胞接种后及接种前后腹腔注射上述制剂,观察其抑瘤作用和荷瘤小鼠脾细胞NK、LAK活性及产生IL－2活性的影响。结果表明,该制剂可明显抑制L5178Y、P815肿瘤生长并能显著增强荷瘤小鼠脾脏NK、LAK活性,增强脾细胞产生IL－2的能力。Abstract: Many kinds of antigen (Staph aureus, S hemolyticus, BCG, et al) immunized SDrats.Dialysate was obtained from spleen and thymus of SD rats by dialysising, andadding low molecular weight(MW≤10KD) dialysate from Lycium chineses etc ChineseMedicine.This preparation is named Ederpinil.Then, L5178Y P815 tumors bearingDBA mice were used as modeals Respectively, after of inoculation of tumors, before andafter of inoculation of tumors, Ederqini were adrninistrated i.p.Then the action of antitumor and protect-treat tumor, the NK, LAK, IL-2 activity tv the 15178Ytumorbaering mice were assaied.The results suggested Ederqini ingection can inhibted thegrowth of L5178Y, P815 and can enhance the IL-2 activity and NK, LAK activitydistinctly.
-
Key words:
- Biological response modifier /
- Ederqini ingection /
- Tumor treatment
-
-
[1] 吴明生.MTT比色分析法在豚鼠淋巴细胞转化试验中的应用.中国实验临床免疫学杂志,1992.4(4):10 [2] 张志强,等.MTT法检测NK和LAK活性的方法学探讨.中国实验临床免疫学杂志,1994,6(3):12 [3] 杨贵贞主编.免疫生物工程纲要与技术.吉林:吉林科学技术出版社.1991:48 [4] 余贺等主编.肿瘤与免疫.上海:上海科学技术出版社.1982:150 [5] 王秀芳,等.拘祀小分子物质对小鼠肿瘤杀伤细胞活性的影响.河北医学,1996,2(6):7 [6] 钱玉昆,等.中药(苦参及构祀子)对免疫细胞和细胞因子的实验调节.中华微生物学和免疫学杂志,1989,8:372
计量
- 文章访问数: 1067
- HTML全文浏览量: 25
- PDF下载量: 308
下载:
